Nebenwirkungen · Pregabalin Viatris Pharma (previously Pregabalin Pfizer)
Pregabalin Viatris Pharma 25 mg hard capsules Pregabalin Viatris Pharma 50 mg hard capsules Pregabalin Viatris Pharma 75 mg hard capsules Pregabalin Viatris Pharma 100 mg hard capsules Pregabalin Viatris Pharma 150 mg hard capsules Pregabalin Viatris Pharma 200 mg hard capsules Pregabalin Viatris Pharma 225 mg hard capsules Pregabalin Viatris Pharma 300 mg hard capsules · Abschnitt 4.8 · PDF-Seite 12
HOS-132676 · Präparat HOS-097274
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-24T15:36:00Z · SHA-256 82ee888afd9191364ca2885cfe33f3a6014857efdff1de95ea2361849731a42c · Passage 42f7144177697b690f59b1bda795c3fd216297691cf296a2e1269a137feab3cd · Zeichen 8967–9322 im Abschnitt